Every 10-Q that UiPath, Inc. (PATH) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow PATH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PATH filings page.
UiPath, Inc. (PATH) reported solid growth and improved profitability for the quarter ended July 31, 2026. Revenue was $410.3 million, up 13% year over year, driven mainly by subscription services, with gross margin of 80% versus 82% a year ago. Net income was $36.1 million compared with $1.6 million in the prior-year quarter, and diluted EPS was $0.07.
For the first six months, revenue reached $828.6 million, up 15%, with net income of $58.6 million versus a loss of $21.0 million a year earlier. Operating cash flow was $162.6 million. Annualized renewal run‑rate (ARR) was $1.94 billion, up 12%, with a dollar‑based net retention rate of 109%. Cash, restricted cash, and marketable securities totaled $1.41 billion, down from $1.69 billion at January 31, 2026, reflecting business acquisitions and $268.5 million of share repurchases. Goodwill increased to $179.5 million following the acquisition of WorkFusion.
UiPath reported a profitable quarter with solid growth. For the three months ended April 30, 2026, revenue reached $418.4 million, up 17% year-over-year, while ARR rose to $1,901.2 million, a 12% increase, driven mainly by expansion within existing customers.
Gross margin stayed high at 82%. UiPath generated operating income of $28.0 million and net income of $22.5 million, compared with a net loss a year earlier. Operating cash flow was $131.9 million, and the company ended the quarter with $1,417.2 million in cash, restricted cash, and marketable securities after acquisitions and share repurchases.
UiPath, Inc. reported solid growth and a swing to profitability for the quarter ended October 31, 2025. Total revenue was $411.1 million, up from $354.7 million a year earlier, driven by increases in licenses, subscription services, and professional services. For the first nine months, revenue reached $1.13 billion, up from $1.01 billion.
Operating results improved markedly. The company generated operating income of $13.1 million versus a prior-year operating loss of $43.4 million, helped by lower sales and marketing spending and strong gross margins. A large income tax benefit of $174.2 million contributed to net income of $198.8 million, compared with a net loss of $10.7 million in the prior-year quarter.
UiPath remains highly liquid, with $743.7 million in cash and cash equivalents and $776.1 million in marketable securities as of October 31, 2025. The company generated $188.9 million of operating cash flow in the first nine months, repurchased 30.2 million Class A shares for $329.1 million, and completed the $40.1 million acquisition of Peak AI Limited to enhance its AI-driven pricing and inventory capabilities.
UiPath reported continued subscription-led growth with improving margins and solid cash generation for the six months ended July 31, 2025. Quarter-to-date revenue was $361.7 million, up 14% year-over-year, and year-to-date revenue was $718.4 million, up 10% year-over-year. Annualized renewal run-rate (ARR) reached $1,723.4 million, an 11% increase, driven mostly by expansion from existing customers. Gross margin held at 82% for the three- and six-month periods. Cash flow from operations was $160.6 million for the six months, while cash, restricted cash, and marketable securities totaled $1,523.1 million at July 31, 2025, down from $1,724.1 million at January 31, 2025. The company completed the acquisition of Peak AI Limited for $40.1 million to gain retail and manufacturing pricing and inventory capabilities. Material contingencies include several securities class actions and shareholder derivative suits and ongoing tax audits and assessments in Romania and India with potential exposures disclosed.